Virginia Callejo-Martinez

Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: September 23, 2025

[Translated article] Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: September 23, 2025

Sex-related differences in the efficacy and toxicity of cancer treatments.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 08, 2024

Sex and gender differences in cancer pathogenesis and pharmacology.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 08, 2024

Pharmaceutical cost savings from the treatment of oncology patients in clinical trials.

Journal: Biomedical journal

Published: December 18, 2023

Severe hepatotoxicity during treatment with capmatinib.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 09, 2023

[Translated article] Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs.

Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria

Published: June 04, 2022

Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.

Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.

[Translated article] Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.

[Translated article] Real-world effectiveness and safety of atezolizumab-carboplatin-etoposide regimen in extensive-stage small-cell lung cancer.

Sex-related differences in the efficacy and toxicity of cancer treatments.

Sex-related differences in the efficacy and toxicity of cancer treatments.

Sex and gender differences in cancer pathogenesis and pharmacology.

Sex and gender differences in cancer pathogenesis and pharmacology.

Pharmaceutical cost savings from the treatment of oncology patients in clinical trials.

Pharmaceutical cost savings from the treatment of oncology patients in clinical trials.

Severe hepatotoxicity during treatment with capmatinib.

Severe hepatotoxicity during treatment with capmatinib.

[Translated article] Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs.

[Translated article] Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs.

Predictive value of immune-related adverse events during pembrolizumab treatment in non-small cell lung cancer.

Predictive value of immune-related adverse events during pembrolizumab treatment in non-small cell lung cancer.

Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.

Pre-clinical development of Listeria-based nanovaccines as immunotherapies for solid tumours: insights from melanoma.